A significant advance in cancer investigation is arising with the use of mini-antibodies to reactivate damaged p53. This essential cancer inhibitor protein is frequently disabled in many types of malignancies, leading https://myeasybookmarks.com/story7638028/mini-antibodies-reactivate-p53-the-potential-pathway-for-malignant-treatment